Clinical trial

Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer

NCT00268593

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention PI-88 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record docetaxel Normalized identity: docetaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record prednisone Normalized identity: prednisoneView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-08-01

PhasePHASE2

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

PI-88DRUG

docetaxelDRUG · verified · RxNorm: docetaxel

prednisoneDRUG · verified · RxNorm: prednisone

Sponsors & collaborators

Progen Pharmaceuticalslead sponsor

Northern Sydney and Central Coast Area Health Servicecollaborator

Aventis Pharmaceuticalscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00268593 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.